The label and legend for Figure 4 are incorrect. The correct label and legend are as follows: Figure 4: Chromatin modifiers. (A) RQ-PCR analysis of USP46 in DLBCL cell lines (left), siRNA-treated SU-DHL-5 cells (middle), and in SU-DHL-4 cells treated for overexpression of HEY1 (right). (B) RQ-PCR analysis of RNF20 (left) and RNF40 (right) in DLBCL cell lines. The data show abundant expression in SU-DHL-5. (C) RQ-PCR analyses show downregulation of RNF20 and NKX2-1 after siRNA-mediated knockdown of RNF20 (left). RQ-PCR analysis show downregulation of RNF40 and NKX2-1 after siRNA-mediated RNF20 knockdown (middle). RQ-PCR analysis shows downregulation of RNF40 after 26 siRNA-mediated knockdown of NKX2-1 (right). (D) RQ-PCR analysis of JMJD3 in DLBCL cell lines (left) and in SU-DHL-5 cells treated for siRNA-mediated knockdown of NKX2-1 (right). (E) RQ-PCR analysis of EZH2 in DLBCL cell lines (left). RQ-PCR analysis of SU-DHL-5 cells treated with EZH2-inhibitor DZNep shows upregulation of NKX2-1 (middle) and of HEY1 (right). (F) RQ-PCR analysis of HOPX in SU-DHL-5 (expression level was set to 1) and in leukemia/lymphoma control cell lines. (G) RQ-PCR analysis shows downregulation of HOPX and NKX2-1 after siRNA-mediated knockdown of HOPX (left). RQ-PCR analysis shows downregulation of NKX2-1 but not of HOPX after siRNAmediated knockdown of NKX2-1 (right). (H) RQ-PCR analysis of E2F6 in DLBCL cell lines (left) and in SU-DHL-5 cells treated for siRNA-mediated knockdown of HEY1 (right).
Citation: Nagel S, Ehrentraut S, Tomasch J, Quentmeier H, Meyer C, Kaufmann M, et al. (2013) Correction: Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications. PLoS ONE 8(6): 10.1371/annotation/3989404d-132f-4f07-a39e-c060d9094611. https://doi.org/10.1371/annotation/3989404d-132f-4f07-a39e-c060d9094611
Published: June 26, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.